Drug Profile
PKI 166
Alternative Names: CGP 75166Latest Information Update: 22 Oct 2002
Price :
$50
*
At a glance
- Originator Novartis
- Class Antineoplastics; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours